First Header Logo Second Header Logo

Yashashwi Pokharel

Concepts (249)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cardiovascular Diseases
15
2023
1125
3.550
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
10
2019
144
2.740
Why?
Dyslipidemias
5
2023
53
2.200
Why?
Practice Guidelines as Topic
10
2018
407
1.860
Why?
Troponin T
4
2019
81
1.740
Why?
Risk Assessment
12
2019
1435
1.690
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
3
2019
9
1.670
Why?
Heart Failure
6
2017
636
1.640
Why?
Diabetes Mellitus
7
2023
411
1.440
Why?
Hypertension
7
2023
957
1.330
Why?
Myocardial Infarction
7
2017
485
1.240
Why?
Cardiology
4
2017
99
1.230
Why?
American Heart Association
4
2017
87
1.220
Why?
United States
24
2023
3938
1.220
Why?
Cholesterol, LDL
3
2019
173
1.210
Why?
Guideline Adherence
7
2018
119
1.210
Why?
Hospitalization
4
2017
470
1.170
Why?
Registries
10
2019
298
1.170
Why?
Atherosclerosis
6
2022
767
1.140
Why?
Football
4
2014
77
1.130
Why?
Retirement
3
2014
12
1.070
Why?
Male
40
2023
19195
1.060
Why?
Middle Aged
30
2020
11868
1.040
Why?
Cognition
2
2019
553
1.000
Why?
Humans
50
2023
32024
0.980
Why?
Female
36
2023
19953
0.930
Why?
Stroke Volume
2
2017
349
0.920
Why?
Risk Factors
21
2019
3869
0.910
Why?
Carotid Artery Diseases
2
2014
114
0.880
Why?
Coronary Artery Disease
4
2016
401
0.850
Why?
Lipoprotein(a)
2
2019
21
0.800
Why?
Intermittent Claudication
2
2018
11
0.790
Why?
Health Status
4
2017
399
0.770
Why?
Coronary Disease
3
2016
213
0.750
Why?
Cholesterol
3
2017
251
0.750
Why?
C-Reactive Protein
3
2017
239
0.720
Why?
Aged
22
2019
10340
0.700
Why?
Natriuretic Peptide, Brain
1
2019
66
0.670
Why?
Apolipoproteins B
1
2019
46
0.660
Why?
Cognition Disorders
2
2019
384
0.650
Why?
Hyperlipoproteinemia Type II
2
2016
17
0.630
Why?
Obesity
4
2023
1179
0.630
Why?
Cardiovascular Agents
2
2016
23
0.630
Why?
Time Factors
13
2019
2152
0.600
Why?
Hospital Costs
1
2017
38
0.570
Why?
Health Status Disparities
1
2018
122
0.570
Why?
Inflammation Mediators
1
2017
105
0.570
Why?
Adult
16
2023
9366
0.560
Why?
Mortality
1
2017
125
0.560
Why?
Medication Therapy Management
1
2016
12
0.560
Why?
Triglycerides
1
2017
230
0.560
Why?
Quality Indicators, Health Care
2
2016
59
0.560
Why?
Forecasting
1
2017
144
0.550
Why?
Cardiomyopathies
1
2016
55
0.550
Why?
Peptide Fragments
1
2019
398
0.550
Why?
Blood Pressure
5
2020
845
0.540
Why?
Inservice Training
1
2016
12
0.540
Why?
Body Mass Index
3
2019
923
0.530
Why?
United States Department of Veterans Affairs
1
2016
62
0.530
Why?
Ambulatory Care Facilities
1
2016
83
0.520
Why?
Education, Medical, Continuing
1
2016
55
0.520
Why?
Apolipoprotein C-III
1
2015
5
0.520
Why?
Prospective Studies
9
2019
2283
0.520
Why?
Lipoprotein Lipase
1
2015
14
0.520
Why?
Health Knowledge, Attitudes, Practice
2
2016
353
0.510
Why?
Proprotein Convertases
1
2015
2
0.510
Why?
Exercise Therapy
1
2018
270
0.510
Why?
Diabetes Complications
1
2016
177
0.510
Why?
Hypercholesterolemia
1
2016
69
0.500
Why?
Acute Coronary Syndrome
1
2017
196
0.490
Why?
Education, Medical, Graduate
1
2016
129
0.490
Why?
Waist Circumference
1
2014
90
0.480
Why?
Enzyme Inhibitors
1
2015
165
0.480
Why?
Comorbidity
7
2017
569
0.470
Why?
Occupations
1
2014
10
0.470
Why?
Ventricular Function, Left
1
2016
243
0.470
Why?
Attitude of Health Personnel
1
2016
182
0.470
Why?
Neck
1
2014
27
0.460
Why?
Healthcare Disparities
1
2016
165
0.460
Why?
Athletes
1
2014
69
0.460
Why?
Platelet Aggregation Inhibitors
4
2019
83
0.450
Why?
European Continental Ancestry Group
1
2018
1169
0.450
Why?
Treatment Outcome
11
2019
3317
0.410
Why?
Incidence
5
2019
1200
0.400
Why?
African Americans
1
2018
1428
0.370
Why?
Lipids
3
2017
229
0.360
Why?
Prognosis
4
2017
1505
0.350
Why?
Cohort Studies
5
2017
1831
0.350
Why?
Drug-Eluting Stents
3
2017
13
0.340
Why?
Calcinosis
3
2014
146
0.340
Why?
Follow-Up Studies
5
2019
2280
0.340
Why?
Stents
3
2017
178
0.310
Why?
Calcium
3
2014
307
0.310
Why?
Linear Models
4
2017
449
0.310
Why?
Logistic Models
6
2017
781
0.310
Why?
Prevalence
6
2017
981
0.300
Why?
Quality of Life
3
2018
932
0.300
Why?
Proportional Hazards Models
4
2017
757
0.290
Why?
Predictive Value of Tests
4
2017
878
0.280
Why?
Postprandial Period
2
2016
10
0.270
Why?
Health Services Accessibility
2
2020
242
0.270
Why?
Chi-Square Distribution
5
2017
298
0.260
Why?
Decision Support Techniques
2
2017
128
0.260
Why?
Drug Prescriptions
2
2016
54
0.260
Why?
Coronary Angiography
3
2017
152
0.260
Why?
Metals
2
2017
18
0.240
Why?
Southeastern United States
1
2023
79
0.230
Why?
Multivariate Analysis
4
2017
687
0.220
Why?
Coronary Vessels
2
2014
160
0.220
Why?
Family Practice
1
2023
51
0.220
Why?
Self Efficacy
1
2023
78
0.220
Why?
Medical History Taking
1
2022
37
0.210
Why?
Refugees
1
2022
7
0.200
Why?
India
3
2016
61
0.200
Why?
Odds Ratio
4
2016
474
0.200
Why?
Hemorrhage
2
2019
100
0.190
Why?
Aged, 80 and over
6
2019
4000
0.190
Why?
Neuropsychological Tests
2
2019
371
0.180
Why?
Health Facilities
1
2020
9
0.180
Why?
North Carolina
2
2023
1516
0.180
Why?
Respiratory Tract Diseases
1
2020
34
0.180
Why?
Up-Regulation
2
2017
189
0.180
Why?
Sodium Chloride, Dietary
1
2020
28
0.170
Why?
Protein Precursors
1
2019
22
0.170
Why?
Models, Statistical
2
2017
173
0.170
Why?
Metabolic Diseases
1
2019
18
0.170
Why?
Peripheral Vascular Diseases
1
2019
35
0.170
Why?
Emigration and Immigration
1
2019
31
0.170
Why?
Apolipoprotein E4
1
2019
63
0.160
Why?
Renal Insufficiency, Chronic
1
2022
288
0.160
Why?
Thinness
1
2019
32
0.160
Why?
Severity of Illness Index
4
2014
900
0.160
Why?
Drug Therapy, Combination
2
2017
286
0.160
Why?
Secondary Prevention
1
2019
63
0.160
Why?
Cross-Sectional Studies
3
2017
1530
0.160
Why?
Lower Extremity
1
2019
100
0.160
Why?
Canada
1
2018
56
0.160
Why?
Sensitivity and Specificity
2
2016
594
0.150
Why?
Cholesterol, HDL
1
2017
177
0.140
Why?
Coronary Restenosis
2
2017
13
0.140
Why?
Recovery of Function
1
2018
200
0.140
Why?
Exercise Tolerance
1
2018
125
0.140
Why?
Cause of Death
1
2017
238
0.140
Why?
Anticholesteremic Agents
1
2017
39
0.140
Why?
Patient Preference
1
2017
47
0.140
Why?
Drug Utilization
1
2016
49
0.140
Why?
Disease Management
1
2017
126
0.130
Why?
Heterozygote
1
2016
57
0.130
Why?
Texas
1
2016
36
0.130
Why?
Cerebrovascular Disorders
1
2016
51
0.130
Why?
Transients and Migrants
1
2019
291
0.130
Why?
Adrenergic beta-Antagonists
1
2016
61
0.130
Why?
Veterans
1
2016
66
0.130
Why?
Angiotensin II Type 1 Receptor Blockers
1
2016
65
0.130
Why?
Double-Blind Method
1
2017
526
0.130
Why?
Developing Countries
1
2016
48
0.130
Why?
Longitudinal Studies
1
2017
771
0.130
Why?
Dose-Response Relationship, Drug
1
2017
629
0.130
Why?
Serine Endopeptidases
1
2015
20
0.130
Why?
Retrospective Studies
3
2022
3523
0.130
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2016
135
0.130
Why?
Monocytes
1
2016
126
0.130
Why?
Ambulatory Care
1
2016
108
0.130
Why?
Genetic Markers
1
2015
124
0.120
Why?
Feasibility Studies
1
2016
292
0.120
Why?
Brain Ischemia
1
2016
145
0.120
Why?
Hyperlipidemias
1
2015
54
0.120
Why?
Genetic Testing
1
2015
96
0.120
Why?
Alleles
1
2015
248
0.120
Why?
Societies, Medical
1
2015
162
0.120
Why?
Databases, Factual
1
2016
355
0.120
Why?
Randomized Controlled Trials as Topic
1
2017
507
0.120
Why?
Anthropometry
1
2014
83
0.120
Why?
Ultrasonography, Doppler
1
2014
24
0.120
Why?
Survival Rate
1
2016
885
0.120
Why?
Carotid Stenosis
1
2014
58
0.120
Why?
Antihypertensive Agents
1
2017
351
0.120
Why?
Angioplasty, Balloon
1
2013
35
0.110
Why?
Primary Health Care
1
2016
227
0.110
Why?
Diabetes Mellitus, Type 2
1
2022
1428
0.110
Why?
Apoptosis
1
2015
354
0.110
Why?
Coronary Thrombosis
1
2012
14
0.110
Why?
Mutation
1
2015
488
0.110
Why?
Clinical Competence
1
2016
333
0.110
Why?
Young Adult
2
2017
2615
0.100
Why?
Atrial Fibrillation
1
2016
321
0.100
Why?
Mass Screening
1
2014
264
0.100
Why?
Inflammation
1
2014
540
0.090
Why?
Smoking
1
2014
500
0.090
Why?
Nepal
2
2020
9
0.090
Why?
Thrombosis
1
2011
73
0.090
Why?
Stroke
1
2015
584
0.090
Why?
Prosthesis Design
2
2017
97
0.060
Why?
Behavioral Risk Factor Surveillance System
1
2022
12
0.050
Why?
Bhutan
1
2022
1
0.050
Why?
Adolescent
2
2022
3526
0.050
Why?
Focus Groups
1
2022
113
0.050
Why?
Public Sector
1
2020
2
0.050
Why?
Private Sector
1
2020
8
0.050
Why?
Respiration Disorders
1
2020
7
0.050
Why?
World Health Organization
1
2020
15
0.050
Why?
Health Resources
1
2020
32
0.050
Why?
Medication Adherence
1
2022
161
0.040
Why?
Health Surveys
1
2020
197
0.040
Why?
Urban Population
1
2020
89
0.040
Why?
Sweden
1
2019
14
0.040
Why?
Middle East
1
2019
5
0.040
Why?
Asia
1
2019
19
0.040
Why?
Hemoglobins
1
2019
49
0.040
Why?
Policy Making
1
2019
20
0.040
Why?
Blood Transfusion
1
2019
74
0.040
Why?
Netherlands
1
2018
22
0.040
Why?
Australia
1
2018
72
0.040
Why?
Rural Population
1
2020
273
0.040
Why?
Spain
1
2017
3
0.040
Why?
Hospital Mortality
1
2019
198
0.040
Why?
Executive Function
1
2017
57
0.040
Why?
Missouri
1
2017
21
0.040
Why?
Retreatment
1
2017
41
0.040
Why?
Drug Costs
1
2017
47
0.040
Why?
Disease Progression
1
2018
594
0.030
Why?
Patient Participation
1
2017
82
0.030
Why?
Early Diagnosis
1
2016
62
0.030
Why?
Residence Characteristics
1
2017
191
0.030
Why?
Risk Reduction Behavior
1
2016
125
0.030
Why?
Down-Regulation
1
2016
142
0.030
Why?
Anticoagulants
1
2016
123
0.030
Why?
Patient Selection
1
2017
277
0.030
Why?
Outpatients
1
2015
57
0.030
Why?
Evidence-Based Medicine
1
2016
217
0.030
Why?
Endarterectomy, Carotid
1
2014
30
0.030
Why?
X-Ray Microtomography
1
2014
40
0.030
Why?
Tissue Culture Techniques
1
2014
40
0.030
Why?
Observer Variation
1
2014
105
0.030
Why?
Biopsy, Needle
1
2014
95
0.030
Why?
Phenotype
1
2016
639
0.030
Why?
Pilot Projects
1
2015
544
0.030
Why?
Image Processing, Computer-Assisted
1
2014
227
0.030
Why?
Immunohistochemistry
1
2014
532
0.030
Why?
Ticlopidine
1
2012
17
0.030
Why?
Myocardial Reperfusion
1
2012
10
0.030
Why?
Age Factors
1
2016
1194
0.030
Why?
Genetic Predisposition to Disease
1
2016
835
0.030
Why?
Confidence Intervals
1
2012
149
0.030
Why?
Health Status Indicators
1
2012
73
0.030
Why?
Propensity Score
1
2011
39
0.020
Why?
Sirolimus
1
2011
33
0.020
Why?
Paclitaxel
1
2011
67
0.020
Why?
Recurrence
1
2011
265
0.020
Why?
Pokharel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (249)
Explore
_
Co-Authors (4)
Explore
_
Same Department Expand Description
Explore
_